Cognetivity Neurosciences

West Point, United States

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

$3.3M raised

Oct 2022

Post-IPO Equity

Artificial Intelligence (AI)Biotechnology Health Care Health Diagnostics Medical Device

Top Investors

Innovate UKRockshield Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cognetivity Neurosciences

How much funding has Cognetivity Neurosciences raised?

Cognetivity Neurosciences has raised $3.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2022.

Who are Cognetivity Neurosciences's investors?

Cognetivity Neurosciences's investors include Innovate UK, Rockshield Capital.

Where is Cognetivity Neurosciences headquartered?

Cognetivity Neurosciences is headquartered in West Point, United States.

What does Cognetivity Neurosciences do?

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

What stage is Cognetivity Neurosciences at?

Cognetivity Neurosciences is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 27, 2022.

MLA

"Cognetivity Neurosciences — Funding & Investors." VCBacked, October 27, 2022, https://www.vcbacked.co/company/cognetivity-neurosciences. Accessed July 1, 2026.

APA

VCBacked. (2022). Cognetivity Neurosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cognetivity-neurosciences

Wikipedia (cite web)

{{cite web |title=Cognetivity Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/cognetivity-neurosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 27, 2022.